Research menu
Jump to menu

Publications:  Dr Lovorka Stojic

Stojic L, Lun ATL, Mascalchi P, Ernst C, Redmond AM, Mangei J, Barr AR, Bousgouni V et al.(2020). A high-content RNAi screen reveals multiple roles for long noncoding RNAs in cell division. Nature Communications vol. 11, (1)
Martinez-Jimenez CP, Eling N, Chen HC, Vallejos CA, Kolodziejczyk AA, Connor F, Stojic L, Rayner TF et al.(2019). Erratum: “Aging increases cell-to-cell transcriptional variability upon immune stimulation”(Science(2020)366:6472 (eaba3487)Doi:10.1126/science.aah4115). Science vol. 366, (6472)
Stojic L, Lun ATL, Mangei J, Mascalchi P, Quarantotti V, Barr AR, Bakal C, Marioni JC et al.(2018). Specificity of RNAi, LNA and CRISPRi as loss-of-function methods in transcriptional analysis. Nucleic Acids Research vol. 46, (12) 5950-5966.
Tichon A, Perry RBT, Stojic L, Ulitsky I(2018). SAM68 is required for regulation of pumilio by the NORAD long noncoding RNA. Genes and Development vol. 32, (1) 70-78.
Chavali PL, Stojic L, Meredith LW, Joseph N, Nahorski MS, Sanford TJ, Sweeney TR, Krishna BA et al.(2017). Neurodevelopmental protein Musashi-1 interacts with the Zika genome and promotes viral replication. Science vol. 357, (6346) 83-88.
Martinez-Jimenez CP, Eling N, Chen HC, Vallejos CA, Kolodziejczyk AA, Connor F, Stojic L, Rayner TF et al.(2017). Aging increases cell-to-cell transcriptional variability upon immune stimulation. Science vol. 355, (6332) 1433-1436.
Ernst C, Pike J, Aitken SJ, Long HK, Eling N, Stojic L, Ward MC, Connor F et al.(2016). Successful transmission and transcriptional deployment of a human chromosome via mouse male meiosis. eLife vol. 5, (NOVEMBER2016)
Murrell A, Stojic L, Niemczyk M (2016). What lies beneath the epigenetic signatures associated with breast cancer and how do we find out?. BREAST CANCER RESEARCH AND TREATMENT. vol. 159, 190-190.
Stojic L, Niemczyk M, Orjalo A, Ito Y, Ruijter AEM, Uribe-Lewis S, Joseph N, Weston S et al.(2016). Transcriptional silencing of long noncoding RNA GNG12-AS1 uncouples its transcriptional and product-related functions. Nature Communications vol. 7,
Uribe-Lewis S, Stark R, Carroll T, Dunning MJ, Bachman M, Ito Y, Stojic L, Halim S et al.(2015). 5-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancer. Genome Biology vol. 16, (1)
Niemczyk M, Ito Y, Huddleston J, Git A, Abu-Amero S, Caldas C, Moore GE, Stojic L et al.(2013). Imprinted chromatin around DIRAS3 regulates alternative splicing of GNG12-AS1, a long noncoding RNA. American Journal of Human Genetics vol. 93, (2) 224-235.
Niemczyk M, Stojic L, Murrell A (2012). DIRAS3 imprinting regulates expression and alternative splicing of a long non-coding RNA, GNG12-AS1 gene. GENETICS RESEARCH. vol. 94, 359-359.
Stojic L, Jasencakova Z, Prezioso C, Stützer A, Bodega B, Pasini D, Klingberg R, Mozzetta C et al.(2011). Chromatin regulated interchange between polycomb repressive complex 2 (PRC2)-Ezh2 and PRC2-Ezh1 complexes controls myogenin activation in skeletal muscle cells. Epigenetics and Chromatin vol. 4, (1)
Borbone E, Troncone G, Ferraro A, Jasencakova Z, Stojic L, Esposito F, Hornig N, Fusco A et al.(2011). Enhancer of zeste homolog 2 overexpression has a role in the development of anaplastic thyroid carcinomas. Journal of Clinical Endocrinology and Metabolism vol. 96, (4) 1029-1038.
Uribe-Lewis S, Woodfine K, Stojic L, Murrell A(2011). Molecular mechanisms of genomic imprinting and clinical implications for cancer. Expert Reviews in Molecular Medicine vol. 13,
Pani E, Stojic L, El-Shemerly M, Jiricny J, Ferrari S(2007). Mismatch repair status and the response of human cells to cisplatin. Cell Cycle vol. 6, (14) 1796-1802.
Stojic L, Cejka P, Jiricny J(2005). High doses of S<inf>N</inf>1 type methylating agents activate DNA damage signaling cascades that are largely independent of mismatch repair. Cell Cycle vol. 4, (3) 473-477.
Stojic L, Brun R, Jiricny J(2004). Mismatch repair and DNA damage signalling. DNA Repair vol. 3, (8-9) 1091-1101.
Stojic L, Mojas N, Cejka P, Di Pietro M, Ferrari S, Marra G, Jiricny J(2004). Mismatch repair-dependent G<inf>2</inf> checjpoint induced by low doses of S<inf>N</inf>1 type methylating agents requires the ATR kinase. Genes and Development vol. 18, (11) 1331-1344.
Cejka P, Stojic L, Marra G, Jiricny J, Brown KD, Baskaran R(2004). Is mismatch repair really required for ionizing radiation-induced DNA damage signaling? [2] (multiple letters). Nature Genetics vol. 36, (5) 432-434.
Di Pietro M, Marra G, Cejka P, Stojic L, Menigatti M, Cattaruzza MS, Jiricny J(2003). Mismatch Repair-Dependent Transcriptome Changes in Human Cells Treated with the Methylating Agent N-Methyl-N′-Nitro-N-Nitrosoguanidine. Cancer Research vol. 63, (23) 8158-8166.
Cejka P, Stojic L, Mojas N, Russell AM, Heinimann K, Cannavó E, Di Pietro M, Marra G et al.(2003). Methylation-induced G<inf>2</inf>/M arrest requires a full complement of the mismatch repair protein hMLH1. EMBO Journal vol. 22, (9) 2245-2254.
Return to top